AAAAAA

   
Results: 1-22 |
Results: 22
Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
Authors: Richon, VM Zhou, XB Rifkind, RA Marks, PA
Citation: Vm. Richon et al., Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers, BL CELL M D, 27(1), 2001, pp. 260-264
Inhibitors of histone deacetylase are potentially effective anticancer agents
Authors: Marks, PA Rifkind, RA Richon, VM Breslow, R
Citation: Pa. Marks et al., Inhibitors of histone deacetylase are potentially effective anticancer agents, CLIN CANC R, 7(4), 2001, pp. 759-760
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
Authors: Butler, LM Webb, Y Agus, DB Higgins, B Tolentino, TR Kutko, MC LaQuaglia, MP Drobnjak, M Cordon-Cardo, C Scher, HI Breslow, R Richon, VM Rifkind, RA Marks, PA
Citation: Lm. Butler et al., Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase, CLIN CANC R, 7(4), 2001, pp. 962-970
Histone deacetylase inhibitors as new cancer drugs
Authors: Marks, PA Richon, VM Breslow, R Rifkind, RA
Citation: Pa. Marks et al., Histone deacetylase inhibitors as new cancer drugs, CURR OPIN O, 13(6), 2001, pp. 477-483
Cloning and characterization of a histone deacetylase, HDAC9
Authors: Zhou, XB Marks, PA Rifkind, RA Richon, VM
Citation: Xb. Zhou et al., Cloning and characterization of a histone deacetylase, HDAC9, P NAS US, 98(19), 2001, pp. 10572-10577
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
Authors: He, LZ Tolentino, T Grayson, P Zhong, S Warrell, RP Rifkind, RA Marks, PA Richon, VM Pandolfi, PP
Citation: Lz. He et al., Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia, J CLIN INV, 108(9), 2001, pp. 1321-1330
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoicacid
Authors: Coffey, DC Kutko, MC Glick, RD Butler, LM Heller, G Rifkind, RA Marks, PA Richon, VM La Quaglia, MP
Citation: Dc. Coffey et al., The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoicacid, CANCER RES, 61(9), 2001, pp. 3591-3594
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
Authors: Munster, PN Troso-Sandoval, T Rosen, N Rifkind, R Marks, PA Richon, VM
Citation: Pn. Munster et al., The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells, CANCER RES, 61(23), 2001, pp. 8492-8497
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
Authors: Marks, PA Richon, VM Rifkind, RA
Citation: Pa. Marks et al., Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells, J NAT CANC, 92(15), 2000, pp. 1210-1216
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
Authors: Coffey, DC Kutko, MC Glick, RD Swendeman, SL Butler, L Rifkind, R Marks, PA Richon, VM LaQuaglia, MP
Citation: Dc. Coffey et al., Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro, MED PED ONC, 35(6), 2000, pp. 577-581
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5
Authors: Zhou, XB Richon, VM Rifkind, RA Marks, PA
Citation: Xb. Zhou et al., Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5, P NAS US, 97(3), 2000, pp. 1056-1061
Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras
Authors: Zhou, XB Richon, VM Wang, AH Yang, XJ Rifkind, RA Marks, PA
Citation: Xb. Zhou et al., Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras, P NAS US, 97(26), 2000, pp. 14329-14333
Histone deacetylase inhibitor selectively induces p21(WAF1) expression andgene-associated histone acetylation
Authors: Richon, VM Sandhoff, TW Rifkind, RA Marks, PA
Citation: Vm. Richon et al., Histone deacetylase inhibitor selectively induces p21(WAF1) expression andgene-associated histone acetylation, P NAS US, 97(18), 2000, pp. 10014-10019
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
Authors: Butler, LM Agus, DB Scher, HI Higgins, B Rose, A Cordon-Cardo, C Thaler, HT Rifkind, RA Marks, PA Richon, VM
Citation: Lm. Butler et al., Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo, CANCER RES, 60(18), 2000, pp. 5165-5170
Health care reform: Has it really begun?
Authors: Marks, PA
Citation: Pa. Marks, Health care reform: Has it really begun?, ACAD MED, 74(3), 1999, pp. 210-212
The conquest of cancer
Authors: Marks, PA
Citation: Pa. Marks, The conquest of cancer, SCIENTIST, 13(2), 1999, pp. 12-12
Hybrid polar inducers of transformed cell differentiation apoptosis. From the cell to the clinic
Authors: Marks, PA Richon, VM Breslow, R Rifkind, RA
Citation: Pa. Marks et al., Hybrid polar inducers of transformed cell differentiation apoptosis. From the cell to the clinic, CR AC S III, 322(2-3), 1999, pp. 161-165
Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiation
Authors: Zhou, XB Richon, VM Ngo, L Rifkind, RA Marks, PA
Citation: Xb. Zhou et al., Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiation, GENE, 233(1-2), 1999, pp. 13-19
Chemoprevention of carcinogen-induced mammary tumorigenesis by the Hybrid Polar Cytodifferentiation agent, suberanilohydroxamic acid (SAHA)
Authors: Cohen, LA Amin, S Marks, PA Rifkind, RA Desai, D Richon, VM
Citation: La. Cohen et al., Chemoprevention of carcinogen-induced mammary tumorigenesis by the Hybrid Polar Cytodifferentiation agent, suberanilohydroxamic acid (SAHA), ANTICANC R, 19(6B), 1999, pp. 4999-5005
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Authors: Finnin, MS Donigian, JR Cohen, A Richon, VM Rifkind, RA Marks, PA Breslow, R Pavletich, NP
Citation: Ms. Finnin et al., Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors, NATURE, 401(6749), 1999, pp. 188-193
Photoaffinity labeling and mass spectrometry identify ribosomal protein S3as a potential target for hybrid polar cytodifferentiation agents
Authors: Webb, Y Zhou, XB Ngo, L Cornish, V Stahl, J Erdjument-Bromage, H Tempst, P Rifkind, RA Marks, PA Breslow, R Richon, VM
Citation: Y. Webb et al., Photoaffinity labeling and mass spectrometry identify ribosomal protein S3as a potential target for hybrid polar cytodifferentiation agents, J BIOL CHEM, 274(20), 1999, pp. 14280-14287
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95ligand expression in human neuroblastoma
Authors: Glick, RD Swendeman, SL Coffey, DC Rifkind, RA Marks, PA Richon, VM La Quaglia, MP
Citation: Rd. Glick et al., Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95ligand expression in human neuroblastoma, CANCER RES, 59(17), 1999, pp. 4392-4399
Risultati: 1-22 |